DMAAR / Drugs Made In America Acquisition Corp. - Equity Right - Net Long/Short Value

Drugs Made In America Acquisition Corp. - Equity Right

DMAAR / Drugs Made In America Acquisition Corp. - Equity Right - Net Long/Short Value
Den här sidan ger nettovärderingarna långa/korta för varje institutionellt innehav som rapporterats via 13F- eller NPORT-anmälningar. För att beräkna nettolångt/kortt värde adderar vi aktievärdet till köpoptionsvärdet och subtraherar säljoptionsvärdet. Fonder som rapporterar kortlånade positioner kommer att rapportera aktievärden som negativa. Långa nettopositioner kommer att ha positiva siffror i kolumnen netto lång/kort, och korta nettopositioner kommer att ha negativa värden i den kolumnen.
Ägare Eget kapitalvärde
($1000)
Call värde
($1000)
Put värde
($1000)
Net Long/Short
($1000)
Mangrove Partners
Toronto Dominion Bank
Harraden Circle Investments, LLC
Highbridge Capital Management Llc
Verition Fund Management LLC
Glazer Capital, Llc
Bulldog Investors, LLP
LMR Partners LLP
Mizuho Securities Usa Llc
Wolverine Asset Management Llc
Hudson Bay Capital Management LP
Cnh Partners Llc
Clear Street Llc
Westchester Capital Management, LLC
Heights Capital Management, Inc
Aristeia Capital Llc
Whitebox Advisors Llc
Mizuho Securities Usa Llc
Quarry LP
Boothbay Fund Management, Llc
Schonfeld Strategic Advisors LLC
Cantor Fitzgerald, L. P.
Crossingbridge Advisors, LLC
Polar Asset Management Partners Inc.
Atw Spac Management Llc
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista